Direct cost analysis of the second year post-allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Centre of Tunisia-Reference-Cited by-同舟云学术

Direct cost analysis of the second year post-allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Centre of Tunisia

Published:2017-01 Issue:1 Volume:5 Page:1335161
ISSN:2001-6689
Container-title:Journal of Market Access & Health Policy
language:en
Short-container-title:Journal of Market Access & Health Policy

Author:

Razgallah Khrouf Myriam¹²,Achour Leila¹²,Thabti Asma¹²,Soussi Mohamed Ali¹²,Abdejelil Nour³⁴,Lazreg Olfa¹,Drira Chema¹²,Zahaf Aida¹,Ladab Saloua³⁴,Ben Othman Tarek³⁴^ORCID

Affiliation:

1. Service Pharmacie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia

2. faculté de Pharmacie de Monastir, Tunisie

3. Service de Greffe et Hématologie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia

4. Université de Tunis El Manar Faculté de Médecine de Tunis, Tunisie

Publisher

Informa UK Limited

Link

https://tandfonline.com/doi/pdf/10.1080/20016689.2017.1335161

Reference12 articles.

1. Costs of Hematopoietic Cell Transplantation: Comparison of Umbilical Cord Blood and Matched Related Donor Transplantation and the Impact of Posttransplant Complications

2. Risk Factors for Readmission after Allogeneic Hematopoietic Stem Cell Transplantation and Impact on Overall Survival

3. A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand

4. Economics of hematopoietic cell transplantation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The incidence and prevalence of serious fungal diseases in Tunisia;Journal of Medical Mycology;2024-06

2. How to improve issuing, transfusion and follow-up of blood components in Southern and Eastern Mediterranean countries? A benchmark assessment;Transfusion and Apheresis Science;2023-04

3. Healthcare resource utilization and costs among patients with steroid-resistant chronic graft-versus-host disease in the United States: a retrospective claims database analysis;Current Medical Research and Opinion;2021-03-10

4. Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease;The European Journal of Health Economics;2020-12-04